June 13, 2025 05:54 PM EDTUpdated 06:30 PM
Deals
Health Tech

For­mer CEO Anne Wo­j­ci­c­ki wins bid for 23andMe

Ngai Yeung

Health Tech Reporter

23andMe said it agreed to sell it­self to co-founder and for­mer CEO Anne Wo­j­ci­c­ki for $305 mil­lion, end­ing a bid­ding war …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Bris­tol My­ers gets a key strate­gist with 'Team Shib­s'; Idor­sia to change CEOs af­ter it 'hit a re­set but­ton'

As­traZeneca inks AI drug R&D deal with Chi­nese phar­ma for $110M up­front 

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times